The litigants in over 20,000 cases involving Ethicon Inc.’s transvaginal mesh have not been able to reach agreement on preserving the mesh taken out of the bodies of women, the plaintiffs said in court papers.
The plaintiffs don’t oppose having a preservation order put in place. But they “oppose the broad scope and ambiguity proposed by defendants in their motion, which requires plaintiffs to advise their healthcare providers to not only preserve explant material but to use ‘appropriate measures for doing so’ and ‘in a condition that enables defendants to do their own testing.’”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
